Advertisement

Tabak-Alkaloide

  • T. Arndt
Living reference work entry
Part of the Springer Reference Medizin book series (SRM)

Zusammenfassung

Tabak-Alkaloide

Literatur

  1. Baselt RC (2014). Disposition of toxic drugs and chemicals in man, 10. Aufl. Biomedical Publications, Seal Beach, S 133–134 und 1452–1456Google Scholar
  2. Blaschek W, Ebel S, Hackenthal E, Holzgrabe U, Keller K, Reichling J, Schulz V (Hrsg) (2007) Hagers Enzyklopädie der Arzneistoffe und Drogen, Bd 11, 6. Aufl. Wissenschaftliche Verlagsgesellschaft – Springer, Stuttgart/Heidelberg, S 431–444Google Scholar
  3. Moyer TP, Charlson JR, Enger RJ, Dale LC, Ebbert JO, Schroeder DR, Hurt RD (2002) Simultaneous analysis of nicotine, nicotine metabolites, and tobacco alkaloids in serum or urine by tandem mass spectrometry, with clinically relevant metabolic profiles. Clin Chem 48:1460–1471PubMedGoogle Scholar
  4. Schulz M, Iwersen-Bergmann S, Andresen H, Schmoldt A (2012) Therapeutic and toxic blood concentrations of nearly 1000 drugs and other xenobiotics. Crit Care 16:R136CrossRefPubMedPubMedCentralGoogle Scholar
  5. von Weymarn LB, Thomson NM, Donny EC, Hatsukami DK, Murphy SE (2016) Quantification of the minor tobacco alkaloids nornicotine, anatabine, and anabasine in smokers’ urine by high throughput liquid chromatography-mass spectrometry. Chem Res Toxicol 29:390–397CrossRefGoogle Scholar

Copyright information

© © Springer-Verlag GmbH Deutschland 2017

Authors and Affiliations

  1. 1.Bioscientia Institut für Medizinische Diagnostik GmbHIngelheimDeutschland

Personalised recommendations